Evotec SE (EVO) Net Cash Flow Growth (1y) (2010 - 2026)
Powered by 
Analysis
Evotec SE (EVO) Net Cash Flow Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn | -115.29% |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 62.26% |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn | 172.35% |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn | 211.46% |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn | 188.66% |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn | 83.98% |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn | -134.25% |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn | 881.88% |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -119.31% |
| Dec 31, 2025 | -149.46% |
| Sep 30, 2025 | -1,074.51% |
| Jun 30, 2025 | 94.72% |
| Mar 31, 2025 | 79.50% |
| Dec 31, 2024 | 370.55% |
| Jun 30, 2024 | -895.94% |
| Mar 31, 2024 | -1,082.02% |
| Dec 31, 2023 | 103.05% |
| Jun 30, 2023 | 0.45% |
| Mar 31, 2023 | 122.39% |
| Dec 31, 2022 | -758.96% |
| Sep 30, 2022 | 157.13% |
| Jun 30, 2022 | -83.01% |
| Mar 31, 2022 | -294.51% |
| Jun 30, 2010 | -86.28% |
| Mar 31, 2010 | -102.10% |